Johnson & Johnson
Ownership
Ownership Structure
Who owns Johnson & Johnson (JNJ)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 99.8% of the shares are freely tradable; institutional investors hold 76.9%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| BlackRock Inc | 8.85 | 213,385,546 | +2.2 | 03/31/2026 |
| Vanguard Capital Management, LLC | 6.50 | 156,605,370 | +0.0 | 03/31/2026 |
| State Street Corp | 5.54 | 133,476,288 | -0.3 | 03/31/2026 |
| Vanguard Portfolio Management, LLC | 2.64 | 63,514,436 | +0.0 | 03/31/2026 |
| JPMorgan Chase & Co | 2.62 | 63,096,344 | +7.7 | 03/31/2026 |
| Geode Capital Management, LLC | 2.46 | 59,164,862 | +2.1 | 03/31/2026 |
| Morgan Stanley - Brokerage Accounts | 1.86 | 44,721,167 | -3.5 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard MStar Total Stk Mkt Idx Invest | 3.18 | 76,652,564 | +0.3 | 07/31/2026 |
| Vanguard 500 Index Investor | 2.62 | 63,192,258 | +1.1 | 07/31/2026 |
| iShares Core S&P 500 ETF | 1.33 | 32,055,505 | -0.2 | 08/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Duato Joaquin | CEO and Chairman of the Board | 275,967 | 74,511,090 $ | Aug 13, 2026 | direct |
| Taubert Jennifer L | EVP, WWC. Innovative Medicine | 194,451 | 52,501,770 $ | Aug 17, 2026 | direct |
| Schmid Timothy | EVP, WW Chair, MedTech | 25,447 | 6,870,690 $ | Sep 2, 2026 | direct |
| Broadhurst Vanessa | EVP, Global Corp Affairs | 23,003 | 6,210,810 $ | Jul 20, 2026 | direct |
| Forminard Elizabeth | EVP, Chief Legal Officer | 16,994 | 4,588,380 $ | Aug 6, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 2, 2026 | Schmid Timothy | EVP, WW Chair, MedTech | Sell | 22,527 | 274.74 | 6,189,068 |
| Sep 2, 2026 | Schmid Timothy | EVP, WW Chair, MedTech | Other | 22,527 | 151.41 | 3,410,813 |
| Sep 2, 2026 | Schmid Timothy | EVP, WW Chair, MedTech | Sell | 11,070 | 274.74 | 3,041,372 |
| Sep 2, 2026 | Schmid Timothy | EVP, WW Chair, MedTech | Other | 11,070 | 131.94 | 1,460,576 |
| Aug 17, 2026 | Taubert Jennifer L | EVP, WWC. Innovative Medicine | Sell | 15,000 | 263.36 | 3,950,400 |
| Aug 17, 2026 | Taubert Jennifer L | EVP, WWC. Innovative Medicine | Other | 15,000 | 115.67 | 1,735,050 |
| Aug 13, 2026 | Duato Joaquin | CEO and Chairman of the Board | Sell | 102,315 | 261.00 | 26,704,215 |
| Aug 13, 2026 | Duato Joaquin | CEO and Chairman of the Board | Sell | 20,976 | 262.00 | 5,495,712 |
| Aug 13, 2026 | Duato Joaquin | CEO and Chairman of the Board | Other | 123,291 | 115.67 | 14,261,070 |
| Aug 6, 2026 | Forminard Elizabeth | EVP, Chief Legal Officer | Sell | 6,574 | 255.93 | 1,682,497 |
| Aug 6, 2026 | Forminard Elizabeth | EVP, Chief Legal Officer | Sell | 9,344 | 257.76 | 2,408,463 |
| Aug 6, 2026 | Forminard Elizabeth | EVP, Chief Legal Officer | Other | 9,344 | 131.94 | 1,232,847 |
| Aug 5, 2026 | Duato Joaquin | CEO and Chairman of the Board | Sell | 6,523 | 258.74 | 1,687,755 |
| Aug 5, 2026 | Duato Joaquin | CEO and Chairman of the Board | Sell | 41,957 | 258.06 | 10,827,256 |
| Jul 20, 2026 | Broadhurst Vanessa | EVP, Global Corp Affairs | Sell | 23,054 | 251.27 | 5,792,686 |
| Jul 20, 2026 | Broadhurst Vanessa | EVP, Global Corp Affairs | Other | 11,925 | 131.94 | 1,573,385 |
| Jul 20, 2026 | Broadhurst Vanessa | EVP, Global Corp Affairs | Other | 11,129 | 129.51 | 1,441,317 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.